In line with Articles 125-130 of the present PIF Code, the company must document and publish the economic benefits targeted at healthcare organisations or professions (persons entitled to prescribe or dispense medicines) who have their principal place of business, work address or registered domicile in Europe.Finland-map-colour
Economic benefit refers to all direct or indirect transfers of economic value either in cash, in benefits in kind or other forms of benefit.
The information obligation does not relate to economic benefits:

  • not included in the categories under Article 125;
  • constituting part of the usual sales and purchasing operations between the pharmaceutical company and healthcare professional or organsaition

[
(as per Sections 124 – 130 of the 2014 version of the  PIF COE)